|
|
Volumn 35, Issue 7, 2003, Pages 2781-2782
|
|
Starting the liver transplant program at King Faisal Specialist Hospital and Research Center in Saudi Arabia: Early experience and future expectations
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
LAMIVUDINE;
LIVER ENZYME;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NYSTATIN;
STEROID;
TACROLIMUS;
ADULT;
ARTERY RECONSTRUCTION;
ARTERY THROMBOSIS;
AUTOIMMUNE HEPATITIS;
BACTERIAL PERITONITIS;
BLOOD TRANSFUSION;
BRAIN DEATH;
BRAIN STEM;
BUDD CHIARI SYNDROME;
CADAVER DONOR;
CHILD;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEMOGRAPHY;
DRUG MEGADOSE;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
HEPATITIS;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HOSPITALIZATION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTENSIVE CARE UNIT;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER FUNCTION TEST;
LIVER TRANSPLANTATION;
LIVING DONOR;
MALE;
MORTALITY;
POSTOPERATIVE PERIOD;
PRIMARY SCLEROSING CHOLANGITIS;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SAUDI ARABIA;
SURGICAL INFECTION;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
TREATMENT OUTCOME;
VEIN BYPASS;
|
|
EID: 0242637211
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.09.031 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (3)
|
